APO Research
Talk to an analyst

APO RESEARCH · REPORT

Olanzapine Orally Disintegrating Tablets

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Olanzapine Orally Disintegrating Tablets Market Analysis and Forecast 2026-2032

29 December 2025196 pages

Choose your research edition.

Industry ResearchOlanzapine Orally Disintegrating Tablets Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Olanzapine Orally Disintegrating Tablets Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Olanzapine Orally Disintegrating Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Olanzapine Orally Disintegrating Tablets Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Olanzapine Orally Disintegrating Tablets Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Olanzapine Orally Disintegrating Tablets market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Olanzapine Orally Disintegrating Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Olanzapine Orally Disintegrating Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Olanzapine Orally Disintegrating Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Olanzapine Orally Disintegrating Tablets is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Olanzapine Orally Disintegrating Tablets include Apotex, Dr. Reddy's Laboratories, PKU HealthCare, QILU Pharmaceutical, Sunshine Lake Pharma, Torrent Pharmaceuticals, Eli Lilly Nederland B.V., Sun Pharmaceutical Industries Ltd. and Teva Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Olanzapine Orally Disintegrating Tablets, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Olanzapine Orally Disintegrating Tablets, also provides the revenue of main regions and countries. Of the upcoming market potential for Olanzapine Orally Disintegrating Tablets, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Olanzapine Orally Disintegrating Tablets revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Olanzapine Orally Disintegrating Tablets market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Olanzapine Orally Disintegrating Tablets revenue, projected growth trends, production technology, application and end-user industry.

Olanzapine Orally Disintegrating Tablets Segment by Company

Apotex

Dr. Reddy's Laboratories

PKU HealthCare

QILU Pharmaceutical

Sunshine Lake Pharma

Torrent Pharmaceuticals

Eli Lilly Nederland B.V.

Sun Pharmaceutical Industries Ltd.

Teva Pharmaceutical

Chengdu Easton Biopharmaceuticals

Olanzapine Orally Disintegrating Tablets Segment by Type

5mg

20mg

15mg

10mg

Olanzapine Orally Disintegrating Tablets Segment by Application

Hospital

Clinic

Others

Olanzapine Orally Disintegrating Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Olanzapine Orally Disintegrating Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Olanzapine Orally Disintegrating Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Olanzapine Orally Disintegrating Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Olanzapine Orally Disintegrating Tablets in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Olanzapine Orally Disintegrating Tablets company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Olanzapine Orally Disintegrating Tablets revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Olanzapine Orally Disintegrating Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 5mg Major Player Table 3. 20mg Major Player Table 4. 15mg Major Player Table 5. 10mg Major Player Table 6. Global Olanzapine Orally Disintegrating Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Major Player Table 8. Clinic Major Player Table 9. Others Major Player Table 10. Olanzapine Orally Disintegrating Tablets Industry Trends Table 11. Olanzapine Orally Disintegrating Tablets Industry Drivers Table 12. Olanzapine Orally Disintegrating Tablets Industry Opportunities and Challenges Table 13. Olanzapine Orally Disintegrating Tablets Industry Restraints Table 14. Global Olanzapine Orally Disintegrating Tablets Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Olanzapine Orally Disintegrating Tablets Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Olanzapine Orally Disintegrating Tablets Market Share by Region (2021-2026) Table 17. Global Olanzapine Orally Disintegrating Tablets Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Olanzapine Orally Disintegrating Tablets Market Share by Region (2027-2032) Table 19. Global Olanzapine Orally Disintegrating Tablets Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Olanzapine Orally Disintegrating Tablets Revenue Market Share by Players (2021-2026) Table 21. Global Olanzapine Orally Disintegrating Tablets Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Olanzapine Orally Disintegrating Tablets Key Players Headquarters & Area Served Table 23. Global Olanzapine Orally Disintegrating Tablets Players, Product Type & Application Table 24. Global Olanzapine Orally Disintegrating Tablets Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Olanzapine Orally Disintegrating Tablets by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Olanzapine Orally Disintegrating Tablets Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Olanzapine Orally Disintegrating Tablets Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Olanzapine Orally Disintegrating Tablets Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Olanzapine Orally Disintegrating Tablets Revenue Market Share by Type (2021-2026) Table 31. Global Olanzapine Orally Disintegrating Tablets Revenue Market Share by Type (2027-2032) Table 32. Global Olanzapine Orally Disintegrating Tablets Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Olanzapine Orally Disintegrating Tablets Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Olanzapine Orally Disintegrating Tablets Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Olanzapine Orally Disintegrating Tablets Revenue Market Share by Application (2021-2026) Table 36. Global Olanzapine Orally Disintegrating Tablets Revenue Market Share by Application (2027-2032) Table 37. Apotex Company Information Table 38. Apotex Business Overview Table 39. Apotex Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Apotex Olanzapine Orally Disintegrating Tablets Product Portfolio Table 41. Apotex Recent Development Table 42. Dr. Reddy's Laboratories Company Information Table 43. Dr. Reddy's Laboratories Business Overview Table 44. Dr. Reddy's Laboratories Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Dr. Reddy's Laboratories Olanzapine Orally Disintegrating Tablets Product Portfolio Table 46. Dr. Reddy's Laboratories Recent Development Table 47. PKU HealthCare Company Information Table 48. PKU HealthCare Business Overview Table 49. PKU HealthCare Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. PKU HealthCare Olanzapine Orally Disintegrating Tablets Product Portfolio Table 51. PKU HealthCare Recent Development Table 52. QILU Pharmaceutical Company Information Table 53. QILU Pharmaceutical Business Overview Table 54. QILU Pharmaceutical Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. QILU Pharmaceutical Olanzapine Orally Disintegrating Tablets Product Portfolio Table 56. QILU Pharmaceutical Recent Development Table 57. Sunshine Lake Pharma Company Information Table 58. Sunshine Lake Pharma Business Overview Table 59. Sunshine Lake Pharma Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Sunshine Lake Pharma Olanzapine Orally Disintegrating Tablets Product Portfolio Table 61. Sunshine Lake Pharma Recent Development Table 62. Torrent Pharmaceuticals Company Information Table 63. Torrent Pharmaceuticals Business Overview Table 64. Torrent Pharmaceuticals Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Torrent Pharmaceuticals Olanzapine Orally Disintegrating Tablets Product Portfolio Table 66. Torrent Pharmaceuticals Recent Development Table 67. Eli Lilly Nederland B.V. Company Information Table 68. Eli Lilly Nederland B.V. Business Overview Table 69. Eli Lilly Nederland B.V. Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Eli Lilly Nederland B.V. Olanzapine Orally Disintegrating Tablets Product Portfolio Table 71. Eli Lilly Nederland B.V. Recent Development Table 72. Sun Pharmaceutical Industries Ltd. Company Information Table 73. Sun Pharmaceutical Industries Ltd. Business Overview Table 74. Sun Pharmaceutical Industries Ltd. Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Sun Pharmaceutical Industries Ltd. Olanzapine Orally Disintegrating Tablets Product Portfolio Table 76. Sun Pharmaceutical Industries Ltd. Recent Development Table 77. Teva Pharmaceutical Company Information Table 78. Teva Pharmaceutical Business Overview Table 79. Teva Pharmaceutical Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Teva Pharmaceutical Olanzapine Orally Disintegrating Tablets Product Portfolio Table 81. Teva Pharmaceutical Recent Development Table 82. Chengdu Easton Biopharmaceuticals Company Information Table 83. Chengdu Easton Biopharmaceuticals Business Overview Table 84. Chengdu Easton Biopharmaceuticals Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Chengdu Easton Biopharmaceuticals Olanzapine Orally Disintegrating Tablets Product Portfolio Table 86. Chengdu Easton Biopharmaceuticals Recent Development Table 87. North America Olanzapine Orally Disintegrating Tablets Revenue by Type (2021-2026) & (US$ Million) Table 88. North America Olanzapine Orally Disintegrating Tablets Revenue by Type (2027-2032) & (US$ Million) Table 89. North America Olanzapine Orally Disintegrating Tablets Revenue by Application (2021-2026) & (US$ Million) Table 90. North America Olanzapine Orally Disintegrating Tablets Revenue by Application (2027-2032) & (US$ Million) Table 91. North America Olanzapine Orally Disintegrating Tablets Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 92. North America Olanzapine Orally Disintegrating Tablets Revenue by Country (2021-2026) & (US$ Million) Table 93. North America Olanzapine Orally Disintegrating Tablets Revenue by Country (US$ Million) & (2027-2032) Table 94. Europe Olanzapine Orally Disintegrating Tablets Revenue by Type (2021-2026) & (US$ Million) Table 95. Europe Olanzapine Orally Disintegrating Tablets Revenue by Type (2027-2032) & (US$ Million) Table 96. Europe Olanzapine Orally Disintegrating Tablets Revenue by Application (2021-2026) & (US$ Million) Table 97. Europe Olanzapine Orally Disintegrating Tablets Revenue by Application (2027-2032) & (US$ Million) Table 98. Europe Olanzapine Orally Disintegrating Tablets Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. Europe Olanzapine Orally Disintegrating Tablets Revenue by Country (2021-2026) & (US$ Million) Table 100. Europe Olanzapine Orally Disintegrating Tablets Revenue by Country (US$ Million) & (2027-2032) Table 101. China Olanzapine Orally Disintegrating Tablets Revenue by Type (2021-2026) & (US$ Million) Table 102. China Olanzapine Orally Disintegrating Tablets Revenue by Type (2027-2032) & (US$ Million) Table 103. China Olanzapine Orally Disintegrating Tablets Revenue by Application (2021-2026) & (US$ Million) Table 104. China Olanzapine Orally Disintegrating Tablets Revenue by Application (2027-2032) & (US$ Million) Table 105. Asia Olanzapine Orally Disintegrating Tablets Revenue by Type (2021-2026) & (US$ Million) Table 106. Asia Olanzapine Orally Disintegrating Tablets Revenue by Type (2027-2032) & (US$ Million) Table 107. Asia Olanzapine Orally Disintegrating Tablets Revenue by Application (2021-2026) & (US$ Million) Table 108. Asia Olanzapine Orally Disintegrating Tablets Revenue by Application (2027-2032) & (US$ Million) Table 109. Asia Olanzapine Orally Disintegrating Tablets Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 110. Asia Olanzapine Orally Disintegrating Tablets Revenue by Region (US$ Million) & (2021-2026) Table 111. Asia Olanzapine Orally Disintegrating Tablets Revenue by Region (US$ Million) & (2027-2032) Table 112. SAMEA Olanzapine Orally Disintegrating Tablets Revenue by Type (2021-2026) & (US$ Million) Table 113. SAMEA Olanzapine Orally Disintegrating Tablets Revenue by Type (2027-2032) & (US$ Million) Table 114. SAMEA Olanzapine Orally Disintegrating Tablets Revenue by Application (2021-2026) & (US$ Million) Table 115. SAMEA Olanzapine Orally Disintegrating Tablets Revenue by Application (2027-2032) & (US$ Million) Table 116. SAMEA Olanzapine Orally Disintegrating Tablets Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. SAMEA Olanzapine Orally Disintegrating Tablets Revenue by Country (2021-2026) & (US$ Million) Table 118. SAMEA Olanzapine Orally Disintegrating Tablets Revenue by Country (US$ Million) & (2027-2032) Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Olanzapine Orally Disintegrating Tablets Image Figure 2. Global Olanzapine Orally Disintegrating Tablets Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Olanzapine Orally Disintegrating Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 4. 5mg Image Figure 5. 20mg Image Figure 6. 15mg Image Figure 7. 10mg Image Figure 8. Global Olanzapine Orally Disintegrating Tablets Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Olanzapine Orally Disintegrating Tablets Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Image Figure 11. Clinic Image Figure 12. Others Image Figure 13. Global Olanzapine Orally Disintegrating Tablets Market Size (US$ Million) & (2021-2032) Figure 14. Global Olanzapine Orally Disintegrating Tablets Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Olanzapine Orally Disintegrating Tablets Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Olanzapine Orally Disintegrating Tablets Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Olanzapine Orally Disintegrating Tablets Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Olanzapine Orally Disintegrating Tablets Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Olanzapine Orally Disintegrating Tablets Revenue Market Share by Type (2021-2032) Figure 21. Global Olanzapine Orally Disintegrating Tablets Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Olanzapine Orally Disintegrating Tablets Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Olanzapine Orally Disintegrating Tablets Revenue Market Share by Application (2021-2032) Figure 24. North America Olanzapine Orally Disintegrating Tablets Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Olanzapine Orally Disintegrating Tablets Revenue Share by Type (2021-2032) Figure 26. North America Olanzapine Orally Disintegrating Tablets Revenue Share by Application (2021-2032) Figure 27. North America Olanzapine Orally Disintegrating Tablets Revenue Share by Country (2021-2032) Figure 28. United States Olanzapine Orally Disintegrating Tablets Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Olanzapine Orally Disintegrating Tablets Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Olanzapine Orally Disintegrating Tablets Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Olanzapine Orally Disintegrating Tablets Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Olanzapine Orally Disintegrating Tablets Revenue Share by Type (2021-2032) Figure 33. Europe Olanzapine Orally Disintegrating Tablets Revenue Share by Application (2021-2032) Figure 34. Europe Olanzapine Orally Disintegrating Tablets Revenue Share by Country (2021-2032) Figure 35. Germany Olanzapine Orally Disintegrating Tablets Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Olanzapine Orally Disintegrating Tablets Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Olanzapine Orally Disintegrating Tablets Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Olanzapine Orally Disintegrating Tablets Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Olanzapine Orally Disintegrating Tablets Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Olanzapine Orally Disintegrating Tablets Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Olanzapine Orally Disintegrating Tablets Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Olanzapine Orally Disintegrating Tablets Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Olanzapine Orally Disintegrating Tablets Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Olanzapine Orally Disintegrating Tablets Revenue Share by Type (2021-2032) Figure 45. China Olanzapine Orally Disintegrating Tablets Revenue Share by Application (2021-2032) Figure 46. Asia Olanzapine Orally Disintegrating Tablets Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Olanzapine Orally Disintegrating Tablets Revenue Share by Type (2021-2032) Figure 48. Asia Olanzapine Orally Disintegrating Tablets Revenue Share by Application (2021-2032) Figure 49. Asia Olanzapine Orally Disintegrating Tablets Revenue Share by Region (2021-2032) Figure 50. Japan Olanzapine Orally Disintegrating Tablets Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Olanzapine Orally Disintegrating Tablets Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Olanzapine Orally Disintegrating Tablets Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Olanzapine Orally Disintegrating Tablets Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Olanzapine Orally Disintegrating Tablets Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Olanzapine Orally Disintegrating Tablets Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Olanzapine Orally Disintegrating Tablets Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Olanzapine Orally Disintegrating Tablets Revenue Share by Type (2021-2032) Figure 58. SAMEA Olanzapine Orally Disintegrating Tablets Revenue Share by Application (2021-2032) Figure 59. SAMEA Olanzapine Orally Disintegrating Tablets Revenue Share by Country (2021-2032) Figure 60. Brazil Olanzapine Orally Disintegrating Tablets Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Olanzapine Orally Disintegrating Tablets Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Olanzapine Orally Disintegrating Tablets Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Olanzapine Orally Disintegrating Tablets Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Olanzapine Orally Disintegrating Tablets Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Olanzapine Orally Disintegrating Tablets Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Olanzapine Orally Disintegrating Tablets Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Olanzapine Orally Disintegrating Tablets Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Olanzapine Orally Disintegrating Tablets Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Olanzapine Orally Disintegrating Tablets Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Olanzapine Orally Disintegrating Tablets Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 5mg
  • 20mg
  • 15mg
  • 10mg
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Apotex
  • Dr. Reddy's Laboratories
  • PKU HealthCare
  • QILU Pharmaceutical
  • Sunshine Lake Pharma
  • Torrent Pharmaceuticals
  • Eli Lilly Nederland B.V.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical
  • Chengdu Easton Biopharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Olanzapine Orally Disintegrating Tablets Market by Type
  3. 1.2.1 Global Olanzapine Orally Disintegrating Tablets Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 5mg
  5. 1.2.3 20mg
  6. 1.2.4 15mg
  7. 1.2.5 10mg
  8. 1.3 Olanzapine Orally Disintegrating Tablets Market by Application
  9. 1.3.1 Global Olanzapine Orally Disintegrating Tablets Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Clinic
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Olanzapine Orally Disintegrating Tablets Market Dynamics
  1. 2.1 Olanzapine Orally Disintegrating Tablets Industry Trends
  2. 2.2 Olanzapine Orally Disintegrating Tablets Industry Drivers
  3. 2.3 Olanzapine Orally Disintegrating Tablets Industry Opportunities and Challenges
  4. 2.4 Olanzapine Orally Disintegrating Tablets Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Olanzapine Orally Disintegrating Tablets Market Perspective (2021-2032)
  2. 3.2 Global Olanzapine Orally Disintegrating Tablets Growth Trends by Region
  3. 3.2.1 Global Olanzapine Orally Disintegrating Tablets Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Olanzapine Orally Disintegrating Tablets Market Size by Region (2021-2026)
  5. 3.2.3 Global Olanzapine Orally Disintegrating Tablets Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Olanzapine Orally Disintegrating Tablets Revenue by Players
  2. 4.1.1 Global Olanzapine Orally Disintegrating Tablets Revenue by Players (2021-2026)
  3. 4.1.2 Global Olanzapine Orally Disintegrating Tablets Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Olanzapine Orally Disintegrating Tablets Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Olanzapine Orally Disintegrating Tablets Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Olanzapine Orally Disintegrating Tablets Key Players Headquarters & Area Served
  7. 4.4 Global Olanzapine Orally Disintegrating Tablets Players, Product Type & Application
  8. 4.5 Global Olanzapine Orally Disintegrating Tablets Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Olanzapine Orally Disintegrating Tablets Market CR5 and HHI
  11. 4.6.3 2025 Olanzapine Orally Disintegrating Tablets Tier 1, Tier 2, and Tier 3
5 Olanzapine Orally Disintegrating Tablets Market Size by Type
  1. 5.1 Global Olanzapine Orally Disintegrating Tablets Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Olanzapine Orally Disintegrating Tablets Revenue by Type (2021-2032)
  3. 5.3 Global Olanzapine Orally Disintegrating Tablets Revenue Market Share by Type (2021-2032)
6 Olanzapine Orally Disintegrating Tablets Market Size by Application
  1. 6.1 Global Olanzapine Orally Disintegrating Tablets Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Olanzapine Orally Disintegrating Tablets Revenue by Application (2021-2032)
  3. 6.3 Global Olanzapine Orally Disintegrating Tablets Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Apotex
  2. 7.1.1 Apotex Company Information
  3. 7.1.2 Apotex Business Overview
  4. 7.1.3 Apotex Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Apotex Olanzapine Orally Disintegrating Tablets Product Portfolio
  6. 7.1.5 Apotex Recent Developments
  7. 7.2 Dr. Reddy's Laboratories
  8. 7.2.1 Dr. Reddy's Laboratories Company Information
  9. 7.2.2 Dr. Reddy's Laboratories Business Overview
  10. 7.2.3 Dr. Reddy's Laboratories Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Dr. Reddy's Laboratories Olanzapine Orally Disintegrating Tablets Product Portfolio
  12. 7.2.5 Dr. Reddy's Laboratories Recent Developments
  13. 7.3 PKU HealthCare
  14. 7.3.1 PKU HealthCare Company Information
  15. 7.3.2 PKU HealthCare Business Overview
  16. 7.3.3 PKU HealthCare Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (2021-2026)
  17. 7.3.4 PKU HealthCare Olanzapine Orally Disintegrating Tablets Product Portfolio
  18. 7.3.5 PKU HealthCare Recent Developments
  19. 7.4 QILU Pharmaceutical
  20. 7.4.1 QILU Pharmaceutical Company Information
  21. 7.4.2 QILU Pharmaceutical Business Overview
  22. 7.4.3 QILU Pharmaceutical Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (2021-2026)
  23. 7.4.4 QILU Pharmaceutical Olanzapine Orally Disintegrating Tablets Product Portfolio
  24. 7.4.5 QILU Pharmaceutical Recent Developments
  25. 7.5 Sunshine Lake Pharma
  26. 7.5.1 Sunshine Lake Pharma Company Information
  27. 7.5.2 Sunshine Lake Pharma Business Overview
  28. 7.5.3 Sunshine Lake Pharma Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Sunshine Lake Pharma Olanzapine Orally Disintegrating Tablets Product Portfolio
  30. 7.5.5 Sunshine Lake Pharma Recent Developments
  31. 7.6 Torrent Pharmaceuticals
  32. 7.6.1 Torrent Pharmaceuticals Company Information
  33. 7.6.2 Torrent Pharmaceuticals Business Overview
  34. 7.6.3 Torrent Pharmaceuticals Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Torrent Pharmaceuticals Olanzapine Orally Disintegrating Tablets Product Portfolio
  36. 7.6.5 Torrent Pharmaceuticals Recent Developments
  37. 7.7 Eli Lilly Nederland B.V.
  38. 7.7.1 Eli Lilly Nederland B.V. Company Information
  39. 7.7.2 Eli Lilly Nederland B.V. Business Overview
  40. 7.7.3 Eli Lilly Nederland B.V. Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Eli Lilly Nederland B.V. Olanzapine Orally Disintegrating Tablets Product Portfolio
  42. 7.7.5 Eli Lilly Nederland B.V. Recent Developments
  43. 7.8 Sun Pharmaceutical Industries Ltd.
  44. 7.8.1 Sun Pharmaceutical Industries Ltd. Company Information
  45. 7.8.2 Sun Pharmaceutical Industries Ltd. Business Overview
  46. 7.8.3 Sun Pharmaceutical Industries Ltd. Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Sun Pharmaceutical Industries Ltd. Olanzapine Orally Disintegrating Tablets Product Portfolio
  48. 7.8.5 Sun Pharmaceutical Industries Ltd. Recent Developments
  49. 7.9 Teva Pharmaceutical
  50. 7.9.1 Teva Pharmaceutical Company Information
  51. 7.9.2 Teva Pharmaceutical Business Overview
  52. 7.9.3 Teva Pharmaceutical Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Teva Pharmaceutical Olanzapine Orally Disintegrating Tablets Product Portfolio
  54. 7.9.5 Teva Pharmaceutical Recent Developments
  55. 7.10 Chengdu Easton Biopharmaceuticals
  56. 7.10.1 Chengdu Easton Biopharmaceuticals Company Information
  57. 7.10.2 Chengdu Easton Biopharmaceuticals Business Overview
  58. 7.10.3 Chengdu Easton Biopharmaceuticals Olanzapine Orally Disintegrating Tablets Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Chengdu Easton Biopharmaceuticals Olanzapine Orally Disintegrating Tablets Product Portfolio
  60. 7.10.5 Chengdu Easton Biopharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Olanzapine Orally Disintegrating Tablets Revenue (2021-2032)
  2. 8.2 North America Olanzapine Orally Disintegrating Tablets Revenue by Type (2021-2032)
  3. 8.2.1 North America Olanzapine Orally Disintegrating Tablets Revenue by Type (2021-2026)
  4. 8.2.2 North America Olanzapine Orally Disintegrating Tablets Revenue by Type (2027-2032)
  5. 8.3 North America Olanzapine Orally Disintegrating Tablets Revenue Share by Type (2021-2032)
  6. 8.4 North America Olanzapine Orally Disintegrating Tablets Revenue by Application (2021-2032)
  7. 8.4.1 North America Olanzapine Orally Disintegrating Tablets Revenue by Application (2021-2026)
  8. 8.4.2 North America Olanzapine Orally Disintegrating Tablets Revenue by Application (2027-2032)
  9. 8.5 North America Olanzapine Orally Disintegrating Tablets Revenue Share by Application (2021-2032)
  10. 8.6 North America Olanzapine Orally Disintegrating Tablets Revenue by Country
  11. 8.6.1 North America Olanzapine Orally Disintegrating Tablets Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Olanzapine Orally Disintegrating Tablets Revenue by Country (2021-2026)
  13. 8.6.3 North America Olanzapine Orally Disintegrating Tablets Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Olanzapine Orally Disintegrating Tablets Revenue (2021-2032)
  2. 9.2 Europe Olanzapine Orally Disintegrating Tablets Revenue by Type (2021-2032)
  3. 9.2.1 Europe Olanzapine Orally Disintegrating Tablets Revenue by Type (2021-2026)
  4. 9.2.2 Europe Olanzapine Orally Disintegrating Tablets Revenue by Type (2027-2032)
  5. 9.3 Europe Olanzapine Orally Disintegrating Tablets Revenue Share by Type (2021-2032)
  6. 9.4 Europe Olanzapine Orally Disintegrating Tablets Revenue by Application (2021-2032)
  7. 9.4.1 Europe Olanzapine Orally Disintegrating Tablets Revenue by Application (2021-2026)
  8. 9.4.2 Europe Olanzapine Orally Disintegrating Tablets Revenue by Application (2027-2032)
  9. 9.5 Europe Olanzapine Orally Disintegrating Tablets Revenue Share by Application (2021-2032)
  10. 9.6 Europe Olanzapine Orally Disintegrating Tablets Revenue by Country
  11. 9.6.1 Europe Olanzapine Orally Disintegrating Tablets Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Olanzapine Orally Disintegrating Tablets Revenue by Country (2021-2026)
  13. 9.6.3 Europe Olanzapine Orally Disintegrating Tablets Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Olanzapine Orally Disintegrating Tablets Revenue (2021-2032)
  2. 10.2 China Olanzapine Orally Disintegrating Tablets Revenue by Type (2021-2032)
  3. 10.2.1 China Olanzapine Orally Disintegrating Tablets Revenue by Type (2021-2026)
  4. 10.2.2 China Olanzapine Orally Disintegrating Tablets Revenue by Type (2027-2032)
  5. 10.3 China Olanzapine Orally Disintegrating Tablets Revenue Share by Type (2021-2032)
  6. 10.4 China Olanzapine Orally Disintegrating Tablets Revenue by Application (2021-2032)
  7. 10.4.1 China Olanzapine Orally Disintegrating Tablets Revenue by Application (2021-2026)
  8. 10.4.2 China Olanzapine Orally Disintegrating Tablets Revenue by Application (2027-2032)
  9. 10.5 China Olanzapine Orally Disintegrating Tablets Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Olanzapine Orally Disintegrating Tablets Revenue (2021-2032)
  2. 11.2 Asia Olanzapine Orally Disintegrating Tablets Revenue by Type (2021-2032)
  3. 11.2.1 Asia Olanzapine Orally Disintegrating Tablets Revenue by Type (2021-2026)
  4. 11.2.2 Asia Olanzapine Orally Disintegrating Tablets Revenue by Type (2027-2032)
  5. 11.3 Asia Olanzapine Orally Disintegrating Tablets Revenue Share by Type (2021-2032)
  6. 11.4 Asia Olanzapine Orally Disintegrating Tablets Revenue by Application (2021-2032)
  7. 11.4.1 Asia Olanzapine Orally Disintegrating Tablets Revenue by Application (2021-2026)
  8. 11.4.2 Asia Olanzapine Orally Disintegrating Tablets Revenue by Application (2027-2032)
  9. 11.5 Asia Olanzapine Orally Disintegrating Tablets Revenue Share by Application (2021-2032)
  10. 11.6 Asia Olanzapine Orally Disintegrating Tablets Revenue by Country
  11. 11.6.1 Asia Olanzapine Orally Disintegrating Tablets Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Olanzapine Orally Disintegrating Tablets Revenue by Country (2021-2026)
  13. 11.6.3 Asia Olanzapine Orally Disintegrating Tablets Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Olanzapine Orally Disintegrating Tablets Revenue (2021-2032)
  2. 12.2 SAMEA Olanzapine Orally Disintegrating Tablets Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Olanzapine Orally Disintegrating Tablets Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Olanzapine Orally Disintegrating Tablets Revenue by Type (2027-2032)
  5. 12.3 SAMEA Olanzapine Orally Disintegrating Tablets Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Olanzapine Orally Disintegrating Tablets Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Olanzapine Orally Disintegrating Tablets Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Olanzapine Orally Disintegrating Tablets Revenue by Application (2027-2032)
  9. 12.5 SAMEA Olanzapine Orally Disintegrating Tablets Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Olanzapine Orally Disintegrating Tablets Revenue by Country
  11. 12.6.1 SAMEA Olanzapine Orally Disintegrating Tablets Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Olanzapine Orally Disintegrating Tablets Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Olanzapine Orally Disintegrating Tablets Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst